EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment

EZH2 inhibitors (EZH2i), a class of small-molecule inhibitors that target EZH2 to exert anti-tumor functions, have just been approved by the US Food and Drug Administration (FDA) in treatment of adults and adolescents with locally advanced or metastatic epithelioid sarcoma. The application of EZH2i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chen, Song, Jiagui, Guo, Zhengyang, Gong, Yueqing, Zhang, Tengrui, Huang, Jiaqi, Cheng, Rui, Yu, Xiaotong, Li, Yanfang, Chen, Li, Ma, Xiaojuan, Sun, Yan, Wang, Yan, Xue, Lixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010515/
https://www.ncbi.nlm.nih.gov/pubmed/35432300
http://dx.doi.org/10.3389/fimmu.2022.857808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010515/
https://www.ncbi.nlm.nih.gov/pubmed/35432300
http://dx.doi.org/10.3389/fimmu.2022.857808

Ejemplares similares